Skip to main content
Log in

Campylobacteriosis des Menschen durch die Subspezies intestinalis und fetus unter Berücksichtigung sechs neuer Erkrankungen

Campylobacteriosis in humans caused by subspecies intestinalis and fetus. Six new diseases

  • Published:
Infection Aims and scope Submit manuscript

Zusammenfassung

Campylobacter fetus Subspeziesintestinalis und Subspeziesfetus sind beim Menschen opportunistische Krankheitserreger. Weltweit wurden bisher etwa 200 Erkrankungen beschrieben. Sechs neue Erkrankungen werden kurz vorgestellt. Am häufigsten ist die Sepsis, gefolgt von Meningitis. Wirksame Antibiotika sind Ticarcillin, Erythromycin, Clindamycin und Tetracyclin; weitgehende Resistenz besteht gegenüber Cefalotin, Cefazolin, Cefuroxim, Cefoxitin und Cefotaxim, mäßige Empfindlichkeit gegenüber Gentamicin. Die Epidemiologie der Erkrankung ist unklar. Männer sind etwa zweimal häufiger betroffen als Frauen. Bei 95% der Erkrankungen wurde die Subspeziesintestinalis isoliert. Bei 3,9% der Bevölkerung wurden Antikörper gegenCampylobacter fetus nachgewiesen.

Summary

The subspeciesintestinalis andfetus ofCampylobacter fetus are opportunistic pathogens in humans. So far, some 200 types of disease due to these pathogens have been reported from all over the world, and six new diseases are briefly described in this paper. The most frequent disease is sepsis, followed by meningitis. While ticarcillin, erythromycin, clindamycin and tetracycline are the antibiotics which show activity against these species, a large degree of resistance is seen against cephalothin, cefazolin, cefuroxime, cefoxitin and cefotaxime. There is a moderate degree of sensitivity to gentamicin. The epidemiology of the disease is not clear, and about twice as many men are affected as women. Subspeciesintestinalis was isolated in 95% of all diseases. Antibodies toCampylobacter fetus were detected in 3.9% of the population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. King, E. O. Human infection withVibrio fetus and a closely related vibrio. J. Infect. Dis. 101 (1957) 119–128.

    Google Scholar 

  2. King, E. O. The laboratory recognition ofVibrio fetus and a closely related vibrio isolated from cases of human vibriosis. Ann. N. 4. Acad. Sci. 98 (1962) 700–711.

    Google Scholar 

  3. Dekeyser, P., Gossuin-Detrain, M., Butzler, J.-P., Sternon, J. Acute enteritis due to related vibrio. First positive stool cultures. J. Infect. Dis. 125 (1972) 390–392.

    Google Scholar 

  4. Butzler, J.-P., Skirrow, M. B. Campylobacter enteritis. Clin. Gastroenterol. 8 (1979) 737–765.

    Google Scholar 

  5. Skirrow, M. B. Campylobacter enteritis: a “new” disease. Br. Med. J. 2 (1977) 9–11.

    Google Scholar 

  6. Mc Fadyean, F., Stockman, S. Report of the departmental committee appointed by the board of agriculture and fisheries to inquire into epizootic abortion. His Majesty's Stationary Office, London 1909, Vol. 3.

    Google Scholar 

  7. Smibert, R. M. The genusCampylobacter. Ann. Rev. Microbiol. 32 (1978) 673–709.

    Google Scholar 

  8. Ullmann, U. Methods inCampylobacter. In:Bergan, T., Norris, J. R. (eds.): Methods in Microbiology, Academic Press, London, New York, Toronto, Sydney, San Francisco 1979, pp. 435–452.

    Google Scholar 

  9. Ullmann, U. Vibrio fetus als Krankheitserreger des Menschen. Dtsch. Med. Wschr. 94 (1969) 2399–2402.

    Google Scholar 

  10. Guerrant, R. L., Lahita, R. G., Winn, W. C., Roberts, R. B. Campylobacteriosis in man: pathogenic mechanismus and review of 91 blood stream infections. Am. J. Med. 65 (1978) 584–591.

    Google Scholar 

  11. Ullmann, U. Die bakteriologische Diagnostik derVibrio fetus-Infektion des Menschen. Zbl. Bakt. Hyg., I. Abt. Orig. A 230 (1975) 480–491.

    Google Scholar 

  12. Vinzent, R., Dumas, J., Picard, N. Septicémie grave au cours de la grossesse, due a un vibrion. Bull. Acad. Nat. Méd. (Paris) 131 (1947) 90–92.

    Google Scholar 

  13. Christ, P. Über Erkrankungen durch anaerobe, nicht sporenbildende Bakterien. Dtsch. Arch. Klin. Med. 203 (1956) 186–200.

    Google Scholar 

  14. Ullmann, U. Seroepidemiological studies withCampylobacter fetus. Zbl. Bakt. Hyg., I. Abt. Orig. A 250 (1981) 554–556.

    Google Scholar 

  15. Karamali, M. A., De Grandis, S., Flemming, P. C. Antimicrobial susceptibility ofCampylobacter jejuni andCampylobacter fetus subsp.fetus to eight cephalosporins with special reference to species differentiation. Antimicrob. Agents Chemother. 18 (1980) 948–951.

    Google Scholar 

  16. Vanhoff, R., Vanderlinden, M. P., Dierickx, R., Lauwers, S., Yourassowski, R., Butzler, J. P. Susceptibility ofCampylobacter subsp.jejuni to twenty-nine antimicrobial agents. Antimicrob. Agents Chemother. 14 (1978) 553–556.

    Google Scholar 

  17. Bokkenheuser, V. Vibrio fetus infection in man. Ten new cases and some epidemiological observations. Am. J. Epidemiol. 91 (1970) 400–409.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ullmann, U., Langmaack, H. & Blasius, C. Campylobacteriosis des Menschen durch die Subspezies intestinalis und fetus unter Berücksichtigung sechs neuer Erkrankungen. Infection 10 (Suppl 2), S64–S66 (1982). https://doi.org/10.1007/BF01640856

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01640856

Navigation